nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Stroke Management in Patients With Known or Suspected Atrial Fibrillation
|
Mandzia, Jennifer L. |
|
2013 |
29 |
7S |
p. S45-S53 9 p. |
artikel |
2 |
Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target
|
Nattel, Stanley |
|
2013 |
29 |
7S |
p. S1-S3 3 p. |
artikel |
3 |
Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants
|
Liew, Aaron |
|
2013 |
29 |
7S |
p. S34-S44 11 p. |
artikel |
4 |
Editorial Board
|
|
|
2013 |
29 |
7S |
p. A2- 1 p. |
artikel |
5 |
Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban
|
Gong, Inna Y. |
|
2013 |
29 |
7S |
p. S24-S33 10 p. |
artikel |
6 |
Information for Readers
|
|
|
2013 |
29 |
7S |
p. A7- 1 p. |
artikel |
7 |
Nonpharmacologic Approaches to Stroke Prevention in Atrial Fibrillation
|
Whitlock, Richard P. |
|
2013 |
29 |
7S |
p. S79-S86 8 p. |
artikel |
8 |
Oral Antithrombotic Therapy in Atrial Fibrillation Associated With Acute or Chronic Coronary Artery Disease
|
Cairns, John A. |
|
2013 |
29 |
7S |
p. S60-S70 11 p. |
artikel |
9 |
Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants
|
Healey, Jeff S. |
|
2013 |
29 |
7S |
p. S54-S59 6 p. |
artikel |
10 |
Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke
|
Ahmad, Yousif |
|
2013 |
29 |
7S |
p. S4-S13 10 p. |
artikel |
11 |
Silent Atrial Fibrillation as a Stroke Risk Factor and Anticoagulation Indication
|
Glotzer, Taya V. |
|
2013 |
29 |
7S |
p. S14-S23 10 p. |
artikel |
12 |
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease
|
Hart, Robert G. |
|
2013 |
29 |
7S |
p. S71-S78 8 p. |
artikel |
13 |
Table of Contents
|
|
|
2013 |
29 |
7S |
p. A3-A4 nvt p. |
artikel |